Alexander Turchin, MD, on Predictors of Declining Insulin Therapy for Type 2 Diabetes

Dr Turchin discusses the findings of his recent study, which identified predictors and consequences of declining insulin therapy among patients with type 2 diabetes. He also explains how endocrinologists and related clinicians treating diabetes can address these areas and reach these patients.

Additional Resources:
Turchin A, Hosomura N, Zhang H, Malmasi S, Shubina M. Predictors and consequences of declining insulin therapy by individuals with type 2 diabetes [Published online February 20, 2020]. Diabetic Med.

For more, visit Endocrinology Consultant.

Alexander Turchin, MD, MS, is an associate professor of medicine at Harvard Medical School, and Director of Quality in Diabetes in the division of Endocrinology, Diabetes and Hypertension at Brigham and Women’s Hospital.